Terminated PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00863395

Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma (CTCL)

Sponsor: University of Minnesota

Interventions skin biopsy

Updated 6 times since 2017 Last updated: Mar 28, 2014 Started: Dec 31, 2008 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from University of Minnesota

See all terminations from University of Minnesota

Other Cutaneous T-Cell Lymphoma trials with similar outcome

Browse all Cutaneous T-Cell Lymphoma trials

A PHASE1/PHASE2 clinical study on Cutaneous T-Cell Lymphoma, this trial is terminated or withdrawn. The trial is conducted by University of Minnesota and has accumulated 6 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1_PHASE2
Nov 2019 — Jan 2021 [monthly]

Terminated PHASE1_PHASE2
Jun 2018 — Nov 2019 [monthly]

Terminated PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1_PHASE2

First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Minnesota

Data source: University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States